Growth Metrics

Keros Therapeutics (KROS) Receivables - Net (2021 - 2025)

Keros Therapeutics posted quarterly Receivables - Net of $3.6 million for Q4 2025, up 30.09% year-on-year from $2.7 million in Q4 2024, and up 2.15% on a QoQ basis from $3.5 million in Q3 2025.

Keros Therapeutics (KROS) has 4 years of Receivables - Net data on file, last reported at $3.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 30.09% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 30.09% YoY), and the FY2025 full-year result was $3.6 million, up 30.09% from the prior year.
  • Receivables - Net for Q4 2025 stood at $3.6 million, up from $3.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $18.0 million in Q4 2021 and bottomed at $4000.0 in Q2 2024.
  • The 4-year median for Receivables - Net is $2.7 million (2024), against an average of $5.6 million.
  • Peak annual rise in Receivables - Net reached 395300.0% in 2025, while the deepest fall reached 30.09% in 2025.
  • A 4-year view of Receivables - Net shows it stood at $18.0 million in 2021, then sank by 99.21% to $143000.0 in 2023, then surged by 1817.48% to $2.7 million in 2024, then jumped by 30.09% to $3.6 million in 2025.
  • The last three Receivables - Net figures came in at $3.6 million (Q4 2025), $3.5 million (Q3 2025), and $15.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Keros Therapeutics 403.85 Mn 116.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.57 Mn
Dec 31, 2025 3.57 Mn
Sep 30, 2025 3.49 Mn
Sep 30, 2025 3.49 Mn
Jun 30, 2025 15.82 Mn
Jun 30, 2025 15.82 Mn
Mar 31, 2025 17.29 Mn
Mar 31, 2025 17.29 Mn
Dec 31, 2024 2.74 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 388,000.00
Sep 30, 2024 388,000.00
Jun 30, 2024 4,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 226,000.00
Mar 31, 2024 226,000.00
Dec 31, 2023 143,000.00
Dec 31, 2023 143,000.00
Dec 31, 2021 18.00 Mn
Dec 31, 2021 18.00 Mn
Jun 30, 2021 100,000.00
Jun 30, 2021 100,000.00